So does CHM know if a safe dose was established?
In layman's terms, the hoped end result of the Core-NK platform is 3rd gen. To get there we will have to work through 2nd and then 3rd gen treatments, at each stage combining researched therapies to create this proposed CORE-NK 3rd gen super-killer of cancer cells.
Will we have to go through 3 phase trial in each case?
ORwill we be able to market each generation?
IF the phase 2 trial of our 1st generation CORE-NK is registrational, will CHM market this as a treatment and use the commercial proceeds to work through 2nd and 3rd gen, at each stage hopefully making a new drug?
Surely CHM would not wait until 3rd gen/phase 2 or 3 if we get some kind of efficacious treatments at earlier generations / phases?
Thanks for answering my questions, you seem to understand what you are talking about.
- Forums
- ASX - By Stock
- CHM
- valuation thoughts
valuation thoughts, page-304
-
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.18M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $11.35K | 702.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1886263 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 168006 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1886263 | 0.016 |
12 | 2236452 | 0.015 |
3 | 708475 | 0.014 |
2 | 222223 | 0.013 |
2 | 83412 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 168006 | 2 |
0.018 | 508453 | 2 |
0.019 | 807601 | 5 |
0.020 | 1523093 | 7 |
0.021 | 282857 | 2 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online